Tobacco Regulatory Science Program (TRSP)
|
Research Initiative
|
FDA
|
OD/DPCPSI/ODP, CSR, NCI, NHLBI, NIAAA, NICHD, NIDA, NIEHS, OD/OER
|
Located in the National Institutes of Health (NIH) Office of Disease Prevention, the Tobacco Regulatory Science Program (TRSP) coordinates the trans-NIH collaborative effort with the US Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP) to conduct research to support its regulatory activities over tobacco products. Within the framework of the Tobacco Control Act, the NIH and FDA formed an interagency partnership to foster tobacco regulatory research. The NIH has the infrastructure for the solicitation, review, and management of research. The FDA has expertise in tobacco regulatory science and the authority and resources to support research responsive to FDA’s regulatory authority. Support from FDA was used to fund grants and to provide administrative support and oversight to manage Funding Opportunity Announcements (FOA), application review, policy implementation and oversight, and communicating and reporting to a variety of sources.
|
Toxin Working Group of the Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NIAID
|
The workgroup holds biweekly meetings to discuss the following: point of regulation of select toxins (Botulinum neurotoxins, Staphylococcal enterotoxins, Abrin, Ricin, Conotoxins, Saxitoxin, Tetrodotoxin, Diacetoxyscirpenol, T-2 toxin), natural environment, toxin exclusion limits, space decontamination, and potential updates to the Centers for Disease Control and Prevention (CDC) manual “Biosafety in Microbiological and Biomedical Laboratories.”
|
Training on Implementing Collaborative Care Model for Behavioral Health Conditions in Nurse-Led Safety-Net Clinics.
|
Training Initiative
|
HRSA
|
NIMH
|
The National Institute of Mental Health (NIMH) and the Health Resources and Services Administration (HRSA) are partnering on an initiative to implement a Collaborative Care model in nurse-led safety net clinics supported by HRSA. NIMH is supporting this initiative via a contract to provide training to the HRSA-funded Nurse Education, Practice, Quality and Retention- Interprofessional Collaborative Practice Program: Behavioral Health Integration (NEPQR-IPCP: BHI) awardees who choose to take part in this initiative. Training will be aimed at ensuring awardees implement the IMPACT Collaborative Model of Depression Care with fidelity. The training will be composed of two phases. Phase 1 aims to establish and deliver an initial training program for successful implementation of collaborative care. Phase 2 aims to provide follow up training and implementation support after the in-person training to ensure fidelity of collaborative care delivery.
|
Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR)
|
Committee, Work group, Advisory group, or Task Force
|
BARDA, CDC, FDA
|
NIAID
|
The presidential declaration issued at the 2009 EU-US summit called for the creation of “a transatlantic task force on urgent antimicrobial resistance issues focused on appropriate therapeutic use of antimicrobial drugs in the medical and veterinary communities, prevention of both healthcare- and community-associated drug-resistant infections, and strategies for improving the pipeline of new antimicrobial drugs, which could be better addressed by intensified cooperation between us.” The objectives of the Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR) are to increase the mutual understanding of US and EU activities and programs relevant to the antimicrobial resistance issues identified in the declaration in order to deepen the transatlantic dialogue, provide opportunities to learn from each other, and promote information exchange, coordination, and cooperation.
|
Trans-NIH Medical Rehabilitation Coordinating Committee
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA, SAMHSA
|
NICHD, CC, CSR, NCCIH, NCI, NEI, NHLBI, NIA, NIAMS, NIBIB, NIDCD, NIDDK, NIMH, NINDS, NINR
|
Pursuant to Public Law 101-613, the National Institutes of Health (NIH) Director established the Medical Rehabilitation Coordinating Committee. The Coordinating Committee makes recommendations to the National Institute of Child Health and Human Development (NICHD) Director and the Director of the National Center for Medical Rehabilitation Research with respect to the content of the research plan and activities that are carried out in conjunction with other components of NIH and with other Federal Government agencies.
|
Trans-NIH Structural Birth Defects Working Group (SBDWG)
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NICHD, NCI, NEI, NHGRI, NHLBI, NIAAA, NIAMS, NIDCD, NIDCR, NIDDK, NIEHS, NINDS
|
The Trans-NIH SBDWG brings together extramural program officials from NIH components whose missions include research into structural birth defects, with the ultimate goal of facilitating advances in our understanding of the etiology, mechanisms, epidemiology, prevention, and treatment of structural birth defects.
|
Trans-NIH Tuberculosis (TB) Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NICHD, FIC, NCATS, NCI, NHLBI, NIAAA, NIAID, NIDA, NIGMS, OD/DPCPSI/OAR
|
The TB Working Group provides a forum for sharing information about NIH-specific TB projects, including both ongoing and proposed research, including extramural funding initiatives. In addition, the working group fosters continual open communication about TB research being conducted across NIH and maintains a consistent message about the importance of NIH intramural and extramural TB research. It also provides an avenue for the introduction of new technology programs of interest and importance for TB research (such as the "human on a chip"). The working group invites guests/speakers from outside NIH and convenes invitations for teleconference participation to other US Government agencies including the Centers for Disease Control and Prevention (CDC) and the US Agency for International Development (USAID).
|
Transformation of PROWL Survey into Electronic Form.
|
Health Survey
|
FDA
|
NEI, NLM
|
In 2016, the Food and Drug Administration (FDA) posted the final version of the Patient-Reported Outcomes with Lasik (PROWL) survey instrument developed in collaboration with the National Eye Institute (NEI) and the Department of Defense (DoD). The survey is intended to collect data to help better understand the potential risk of severe problems that can result from LASIK. The NEI is collaborating with the National Library of Medicine (NLM) to recreate the form in an electronic format to allow for incorporation in electronic data capture systems.
The collaboration worked to make the raw data more accessible and deposited in the Biomedical Research Informatics Computing System (Jan 2018).
|
Transplant Cancer Match Study
|
Research Initiative
|
HRSA
|
NCI
|
A study linking databases of US transplant recipients, donors, and waitlist candidates to multiple US cancer registries to evaluate the spectrum of cancer risk in transplant recipients.
|
Traumatic Brain Injury Common Data Elements Standards - Interagency Steering Committee
|
Resource Development
|
CDC
|
NINDS, CIT
|
The Traumatic Brain Injury (TBI) Common Data Elements (CDE) Standards - Interagency Steering Committee provides oversight to a Federal scientific initiative to develop and utilize common data elements for TBI.
|